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We have examined the consequences of cleaving the fusion glycoprotein (F) of human respiratory syncytial virus (HRSV)
at two distinct furin-recognition sites. Purified anchorless F is a mixture of unaggregated cone-shaped molecules and
rosettes of lollipop-shaped spikes. The unaggregated molecules contain a proportion of uncleaved F0 and an intermediate,
F1–109, cleaved only at site I, residues 106–109. Inhibition of cleavage at site I, by two amino acid changes (R108N/R109N),
reduces the proportion of aggregated molecules with a concomitant increase in the amount of unprocessed F0. Inhibition of
cleavage at site II, residues 131–136, by deletion of four amino acids (131–134), abrogates aggregation of anchorless F and
all molecules are seen as individual cone-shaped rods. In vitro cleavage of anchorless F, or mutant 131–134, with trypsin
at 4, 20, or 37°C, under conditions in which cleavage at site II is complete in all molecules, leads to their aggregation in
rosettes of lollipop-shaped spikes. Thus, cleavage at site II is required for the structural changes in anchorless F that lead
to changes in shape and to aggregation. The segment between sites I and II, residues 110–136, is not associated withINTRODUCTION
The replicative cycle of human respiratory syncytial
virus (HRSV, classified in the Pneumovirus genus of the
Paramyxoviridae family) is thought to follow the general
pattern of other paramyxoviruses (Collins et al., 2001).
The initial stages are binding of the virus to the cell
surface through the attachment (G) protein (Levine et al.,
1987) followed by fusion of the viral and cell membranes
by the action of the fusion (F) protein (Walsh and Hruska,
1983). The F protein also mediates fusion of the mem-
branes of infected cells with those of adjacent cells
leading to formation of syncytia. G and F are the two
main surface glycoproteins found in the virus particle
and are also abundantly present on the surface of in-
fected cells. A third small hydrophobic (SH) protein en-
coded by HRSV is also expressed to high levels on the
surface of infected cells but it is incorporated inefficiently
in the virus particle (Collins and Mottet, 1993). SH in-
duces membrane permeability changes when expressed
in bacteria (Perez et al., 1997) but its function in virus
replication is unknown.
HRSV enters the cell by fusion at the plasma mem-
brane rather than by endocytosis (Srinivasakumar et al.,3171991). There have been reports that G and SH enhance
the formation of syncytia mediated by F when the three
proteins are expressed in the same cell (Heminway et
al., 1994; Pastey and Samal, 1997). It was then assumed
that G and SH could also enhance fusion of the viral and
cell membranes mediated by F. However, spontaneous
mutants (Karron et al., 1997) or genetically engineered
recombinants of HRSV that lack G and/or SH (Bukreyev
et al., 1997; Techaarpornkul et al., 2001) can still infect
certain cell types (e.g., Vero cells) and induce formation
of syncytia. Thus, although G and SH proteins may facil-
itate membrane fusion, it is clear that membrane fusion
activity is a property of the F protein.
The F protein is a type I glycoprotein that is synthe-
sized as an inactive polypeptide precursor (F0) of 574
amino acids (Collins et al., 1984) (see Fig. 1A for a
diagram of the primary structure). The precursor is trans-
located into the endoplasmic reticulum (ER) where it
oligomerizes into trimers and is N-linked glycosylated
(Collins and Mottet, 1991). During its transport to the cell
membrane, F0 is proteolytically cleaved by furin to gen-
erate two chains (F2 N-terminal to F1) that remain co-
valently linked by a disulfide bond. The F primary struc-
ture has three main hydrophobic regions: one, at the
N-terminus, which acts as the signal peptide for trans-anchorless F in the supernatant of infected cell cultures,
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terminus; and a third region at the N-terminus of the F1
chain that is called the fusion peptide because it is
thought by analogy with other fusion peptides (Durrer et
al., 1996) to be inserted into the target membrane during
the process of membrane fusion.
We have reported that purified HRSV F protein is seen
by electron microscopy (EM) as rosettes of rods with two
different shapes: cones and lollipops. The rosettes are
formed by aggregation of individual rods through their
transmembrane regions. A mutant anchorless form of F
that lacks the transmembrane region and the cytoplas-
mic tail (FTM) is seen mainly as unaggregated rods,
although a significant proportion (ca. 20%) of rosetted
lollipop-shaped rods can also be observed (Calder et al.,
2000). Preparations of both F and FTM contain, in addi-
tion to molecules cleaved to F1 and F2 chains, uncleaved
F0 molecules, without the signal peptide, and partially
processed intermediates called F1–109 and F2*. F1–109 is
generated by cleavage after residue 109, at a recently
identified furin site, called site I. F2* is generated by
cleavage after residue 136, at a second furin site II
located 27 amino acids C-terminal to site I (Gonza´lez-
Reyes et al., 2001). Site II immediately precedes the
fusion peptide and therefore is equivalent to the single
furin site found in the F protein of other paramyxoviruses
(Chambers et al., 1992). The two-furin sites are also
present in the F protein of the closely related bovine RSV
(Zimmer et al., 2001) but not in the F protein of other
pneumoviruses. Cleavage of F at sites I and II is required
for acquiring full potential of membrane fusion, as as-
sessed in a syncytium formation assay (Gonza´lez-Reyes
et al., 2001).
When purified FTM is treated with trypsin for comple-
tion of cleavage at sites I and II, the unaggregated
FIG. 1. Western blot of purified anchorless F proteins: (A) diagram of the F protein primary structure, denoting hydrophobic regions ( ), cysteine
residues (F), potential N-glycosylation sites (‚), and proteolytic sites I and II (). A partial amino acid sequence of F, including the two cleavage sites
(highlighted in boldface), is shown above the diagram. Diagrams of the anchorless mutant that lacks the C-terminal 50 amino acids, and of the
polypeptides that are generated by processing of anchorless F0 at either site I or site II or at both sites, are also shown. (B) Western blots of purified
anchorless F (Long strain) containing either the wild-type sequence (FTM) or the alterations at site I (R108N/R109N) or site II (131–134), with the
antisera indicated above each panel. The position of F0, F1–109, F1, F2*, and F2 is indicated on the left. The SDS–PAGE gels of this figure and those
of Figs. 2, 4, and 5 were 5 cm long and 12% polyacrylamide.
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cone-shaped molecules become rosettes of lollipop-
shaped rods (Go´nzalez-Reyes et al., 2001). The aggrega-
tion of anchorless F occurs probably through interactions
of the fusion peptides of trimers, since this peptide is the
only highly hydrophobic sequence remaining in anchor-
less F. Thus, completion of proteolytic cleavage in puri-
fied anchorless F leads to exposure of the fusion peptide
and to a change from cone shape to lollipop shape. This
change in shape may be related to activation of the F
protein for its role in membrane fusion and cones and
lollipops may represent the pre- and postactivated forms
of the F protein.
In this study, we have addressed the relevance of
processing at each furin site in the anchorless F protein
for changes in shape and aggregation. In addition, we
have examined the effect of temperature on those
changes and have investigated the fate of the interven-
ing segment, residues 110–136, between proteolytic sites
I and II.
RESULTS
Mutations in sites I and II have different effects on
cleavage of anchorless F
To test the relevance of proteolytic sites I and II for the
aggregation properties of the F molecule, we introduced
mutations at each of these sites in a cDNA copy of the
FTM gene and generated vaccinia recombinants that
expressed the mutant proteins. Two mutants were se-
lected for the present study: mutant R108N/R109N that
has two amino acid substitutions in furin site I and
mutant 131–134 that has a four amino acid deletion in
furin site II (Fig. 1). The proteins were purified by affinity
chromatography and assayed by Western blot with anti-
sera raised against either a 21 amino acid peptide of the
F1 chain (anti-F255–275), a peptide encompassing amino
acids 104–117 (anti-F104–117), or a chimeric GST-F26–136 (anti-
F26–136).
Figure 1B shows that anti-F255–275 serum recognized a
major band of F1 in wild-type anchorless F and two
minor bands corresponding to the previously character-
ized F0 uncleaved precursor and to the proteolytic inter-
mediate F1–109, cleaved only at site I. Mutant R108N/
R109N lacked the F1–109 intermediate product, as ex-
pected by the absence of site I, and showed an increase
in the proportion of F0 with respect to F1. Mutant 131–
134 lacked the F1 chain, indicating that processing at
site II was inhibited, and it had a decreased proportion of
F0 compared with the wild-type protein. The anti-F104–117
and anti-F26–136 sera recognized the F0 precursor, the
intermediate F1–109, and the extended F2 chain (F2*), but
only the anti-F26–136 serum reacted with the fully pro-
cessed F2 chain.
Densitometry of the bands reacting with the anti-
F255–275 serum in the Western blot of Fig. 1B yielded the
following results: F0 represented 12.5% of the three
bands present in wild-type FTM, F1–109 represented
34.3%, and F1 represented 53.2%. In mutant 131–134, F0
represented 10.6% and F1–109 represented 89.4%. In mu-
tant R108N/R109N, F0 represented 35.2% and F1 repre-
sented 64.8%. Similar values were obtained from Coo-
massie-stained gels of the three proteins. From these
results, it can be concluded that cleavage at sites I and
II are independent of each other, as previously reported
(Gonza´lez-Reyes et al., 2001). However, when only a
single furin site is present in anchorless F, cleavage at
site I is more efficient than cleavage at site II. This may
reflect the situation in the wild-type anchorless F and it is
possible that cleavage at site I facilitates cleavage at site
II, consistent with the observation that F0 is less abun-
dant than F1–109 in preparations of FTM (Fig. 1B).
Effect of mutations in sites I and II on shape and
aggregation of anchorless F
The aggregation state of each protein from Fig. 1 was
tested by sedimentation in 10–25% sucrose gradients.
Figure 2 shows Western blots of the gradient fractions for
each protein revealed with either the anti-F255–275 or the
anti-F26–136 sera (Figs. 2A, 2B, and 2C), and quantitation of
the F0, F1–109, and F1 bands from the Western blots with
the anti-F255–275 serum (Figs. 2A, 2B, and 2C).
The wild-type anchorless F protein sedimented
throughout the gradient (Figs. 2A and 2A). However,
whereas the mature F1 chain was distributed almost
uniformly from fractions 4 to 13, the F0 and the F1–109
intermediate were mainly in the fractions near the top of
the gradient, suggesting that only fully processed mole-
cules formed aggregates that sedimented toward the
bottom of the tube. The F2 band showed a sedimentation
profile similar to that of the F1 band.
In the case of mutant R108N/R109N, the majority of the
protein remained near the top of the gradient (Figs. 2B
and 2B). Again, the F0 band of mutant R108N/R109N
was present only in fractions of lower density, whereas a
proportion of the F1 and F2* bands sedimented in frac-
tions of higher density, indicating that some aggrega-
tion occurred even if the protein had been cleaved only
at site II.
In the case of mutant 131–134, the main bands cor-
responded to the intermediate F1–109 and the F2 chain
(Figs. 2C and 2C). These bands and the F0 band sedi-
mented as a symmetrical peak near the top of the gra-
dient and no aggregated forms were observed.
The three proteins of Fig. 1 and the proteins recovered
from fractions 4 and 7 of each gradient shown in Fig. 2
were observed under EM after negative staining (Fig. 3).
Wild-type FTM showed a mixture of individual cone-
shaped rods and rosetted lollipops before the gradient,
whereas mutant R108N/R109N contained less rosettes
with fewer lollipop-shaped spikes than the wild-type.
Mutant 131–134 contained only unaggregated cone-
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shaped rods. The three proteins recovered from fraction
4 of the gradients were seen as individual cone-shaped
rods (Fig. 3, middle panels), confirming that proteins
sedimenting near the top of the gradients are unaggre-
gated. Fraction 7 from the gradient with the wild-type
protein contained essentially all molecules in rosettes of
lollipop-shaped spikes. The same fraction from the gra-
dient of mutant R108N/R109N also contained rosettes of
lollipop-shaped rods and a low proportion of unaggre-
gated cones. However, the protein present in fraction 7 of
the gradient with mutant 131–134 was seen as unag-
gregated cone-shaped molecules (Fig. 3, lower panels).
Thus, the results of Fig. 3 were in agreement with the
sedimentation properties observed for each protein in
the gradients of Fig. 2.
Effect of trypsin and temperature on shape and
aggregation properties of anchorless F
We have shown previously that FTM treated with tryp-
sin at 37°C, under conditions in which F0 and F1–109 are
fully processed, aggregated in rosettes of lollipop-
shaped rods (Gonza´lez-Reyes et al., 2001). Since trypsin
digestion was done at 37°C, it is possible that the ob-
served changes resulted from a combined effect of
cleavage and temperature. Thus, we tested whether tryp-
sin digestion at 4°C would induce similar changes in
FTM. Mutant 131–134 that is fully unaggregated was
also digested with trypsin. The results of Fig. 4 indicate
that cleavage with trypsin of F0 and F1–109 in wild-type
FTM proceeded at 4°C in a dose-dependent manner. The
amount of F1 remained essentially unchanged even with
the highest amount of trypsin, although a low proportion
of bands moving faster than F1 were observed at high
concentrations of trypsin. Cleavage of mutant 131–134
by trypsin followed essentially the same pattern as in the
wild-type, except that an intermediate band between
F1–109 and F1 (indicated by an asterisk in Fig. 4) and other
low molecular weight bands were in greater proportion
in the mutant than in the wild-type. In addition, the F1
band of the mutant did not reach the levels observed in
the wild-type protein at high trypsin concentrations.
These differences between wild-type FTM and mutant
FIG. 2. Sucrose gradients of wild-type and mutant proteins: 400 g (A and C) or 200 g (B) of purified proteins shown in Fig. 1 were sedimented
through 10–25% sucrose gradients (see Materials and Methods). Panels on the left show Western blots of the gradient fractions of wild-type
anchorless F (A), mutant R108N/R109N (B), and mutant 131–134 (C) with either anti-F255–275 (upper part) or anti-F26–136 sera (lower part). Panels on the
right show quantitation by densitometry (a.u., arbitrary units) of the F0 (f—f), F1–109 (F—F), and F1 (Œ—Œ) bands present in the corresponding
Western blots done with anti-F255–275 serum.
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131–134 in the pattern of trypsin products presumably
reflect differences in the susceptibility to trypsin of furin
site II in wild-type FTM and the modified site in 131–134.
When the wild-type anchorless F and the mutant pro-
teins, either untreated or treated with trypsin at 4°C,
were analyzed in sucrose gradients, we observed a
change in the sedimentation profile similar to that re-
ported for the FTM protein treated at 37°C (Gonza´lez-
Reyes et al., 2001). Thus, a shift of the F1 chain toward
fractions in the bottom half of the gradient was noticed
with the wild-type protein (Fig. 5). Simultaneously, the
material sedimenting at the bottom of the tube (seen as
large aggregates under the EM, not shown) was lost
probably because trypsin digestion of contaminants in
the preparation of FTM that contributed to formation of
large aggregates. In the case of mutant 131–134 the
change in sedimentation after trypsin treatment was
even more evident, since the untreated protein remained
near the top of the gradient, whereas the trypsin-treated
sample sedimented as a broad band in fractions of
higher density. Essentially the same results were ob-
tained when the two proteins were digested with trypsin
at 20°C (not shown).
Electron microscopy of the proteins from Fig. 5 con-
firmed that before trypsin treatment the wild-type anchor-
less F was a mixture of individual cones and aggregated
lollipops, whereas the mutant 131–134 was seen as
unaggregated cone-shaped rods (Fig. 6, left panels). In
FIG. 3. Electron microscopy of purified FTM and mutant proteins: the three purified proteins of Fig. 1 were processed for negative staining (upper
panels), as well as the proteins recovered from fractions 4 (middle panels) and 7 (lower panels) of the gradients shown in Fig. 2. The samples were
observed under EM at 30,000 magnification. Note the presence of lipid vesicles in some preparations of purified proteins and in fractions 7 that
do not alter interpretation of the results.
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agreement with the sedimentation results, the wild-type
and the mutant anchorless F proteins aggregated in
rosettes of lollipop-shaped rods after trypsin treatment at
either 4°C (Fig. 6, middle panels) or 20°C (Fig. 6, right
panels). Thus, cleavage at site II, independently of tem-
perature, seems to be responsible for the major changes
in shape and aggregation of anchorless F.
Fate of the intervening segment between proteolytic
sites I and II
The sequence between sites I and II of the F polypep-
tide may either remain noncovalently bound or be re-
leased from the mature F after completion of proteolytic
processing. Since the anti-F104–117 serum recognizes se-
quences located in the F2* band, but not in F2 (Fig. 1B),
we used this reagent to search for the intervening seg-
ment between sites I and II of anchorless F.
HEp-2 cells were infected with the vaccinia recombi-
nant VAC-FTM and metabolically labeled with Pro-mixL-
[35S] from 4 to 28 h after infection. Then, anchorless F
was immunoprecipitated from the culture supernatants
with either the anti-F255–275 or the anti-F104–117 sera and
analyzed by SDS–PAGE and fluorography (Fig. 7). The
anti-F255–275 serum immunoprecipitated several bands
that were not present in the supernatant of cells infected
with the parental vaccinia virus and that corresponded to
F0, F1–109, F1, and F2. The anti-F104–117 serum immunopre-
cipitated the same four bands and, in addition, a wide
band that migrated ahead of the F2 chain and that
masked F2. This extra band was tentatively identified as
the intervening segment between sites I and II (hereafter
named F110–136), considering the peptide size and the
mass contributed by carbohydrates that might be linked
to the three potential sites for N-glycosylation present in
that segment.
The fact that F110–136 was immunoprecipitated by anti-
F104–117 but not by anti-F255–275 suggested that the interven-
ing segment between sites I and II was not bound to FTM
in the supernatant of VAC-FTM-infected cells. To test this
hypothesis, the same supernatant was concentrated
with two types of Centricon membranes, 3 and 30, with
size exclusions of 3000 and 30,000 Da, respectively.
Immunoprecipitation of the concentrate of Centricon 3
FIG. 4. Digestion of anchorless F proteins with trypsin at 4°C: 1 g
of the indicated proteins was incubated with the amount of trypsin
indicated above each lane for 1 h at 4°C in a total volume of 10 l.
Then, each sample was diluted with electrophoresis sample buffer and
analyzed by Western blot with the anti-F255–275 serum. The extra band
observed in mutant 131–134 after trypsin digestion is denoted by an
asterisk.
FIG. 5. Sucrose gradients of anchorless F proteins digested with trypsin at 4°C: purified FTM or 131–134 were either mock digested (upper panels)
or digested with trypsin (lower panels) under the same conditions described in Fig. 4 for the highest amount of enzyme. The proteins were loaded
on 10–25% sucrose gradients that were centrifuged as described under Materials and Methods. Aliquots of the gradient fractions were analyzed by
Western blot with the anti-F255–275 serum.” denotes F1–109 and ‹ denotes F1. Note some bands in fraction 4 of the gradient of 131–134 treated with
trypsin which do not match bands in other fractions and that may represent products of partially degraded trimers unable to aggregate.
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yielded the same results as the original supernatant.
However, F110–136 was absent from the immunoprecipitate
after concentration with Centricon 30, as expected by its
size. Moreover, the immunoprecipitate of the Centricon
30 filtrate with anti-F104–117 contained only the F110–136 band,
indicating that it is not associated with mature anchor-
less F in the supernatant of the VAC-FTM-infected cells.
Neither anti-F255–275 nor anti-F104–117 sera immunoprecipi-
tated any radiolabeled material from the Centricon 3
filtrate.
It is worth emphasizing that anti-F104–117 immunopre-
cipitated F1 and F2 (Fig. 7), although they are not directly
recognized by the antibodies present in that serum (Fig.
1B). The simplest interpretation of this result is that fully
processed monomers of disulfide-linked F1 and F2
chains may coexist in some F trimers with monomers
cleaved only in site I (F1–109) or uncleaved (F0) and that
were brought down by the anti-F104–117 serum.
DISCUSSION
We have reported previously that proteolytic process-
ing of the F protein of HRSV occurs at two distinct sites
(I and II) that are separated by 27 amino acids and that
are each preceded by furin-recognition motifs. The same
cleavage occurs in an anchorless mutant F that lacks the
transmembrane and cytoplasmic tail (Gonza´lez-Reyes et
al., 2001). As found with other viral membrane glycopro-
teins (e.g., Wrigley et al., 1986), purified full-length F
forms aggregates that are seen in the EM as rosettes of
protein rods. In the case of full-length HRSV F, the ro-
settes contain two types of protein rods, one cone-
shaped and the other lollipop-shaped. In contrast, puri-
fied anchorless F contains a mixture of unaggregated
cone-shaped rods and rosetted lollipop-shaped rods
(Calder et al., 2000). Preparations of full-length F or
anchorless F contain a proportion of uncleaved mole-
cules and molecules that are cleaved only at site I.
Completion of cleavage with trypsin at both sites I and II
leads to a change in shape from cones to lollipops and
to aggregation into rosettes of all molecules of anchor-
less F (Gonza´lez-Reyes et al., 2001). These results sug-
gested that following cleavage at sites I and II associa-
tion of the fusion peptides of anchorless F molecule lead
to their aggregation. Since cleavage at sites I and II was
required by full-length F for activity in syncytia formation,
the changes in shape and aggregation properties asso-
ciated with cleavage may be directly related to activation
of F for its role in membrane fusion.
In this article we have evaluated separately the rele-
vance of cleavage at site I or site II, or at both sites, for
FIG. 6. Electron microscopy of anchorless F proteins digested with trypsin at 4 or 20°C: purified FTM or mutant 131–134 (left panels) were
observed in the EM after negative staining. Aliquots of the two proteins were digested with trypsin, as shown in Fig. 4 for the highest amount of
enzyme, at either 4°C (middle panels) or 20°C (right panels), before being observed in the EM.
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the structural changes. Inhibition of cleavage at site I in
the mutant R108N/R109N reduced the proportion of ag-
gregates compared with the wild-type, as assessed by
sucrose density gradient sedimentation (Fig. 2). The ag-
gregates of this mutant contained the F1 chain and the
extended F2* chain, which includes F2 linked to the
intervening segment (F110–136) between sites I and II. Thus,
cleavage at site II alone seems to be sufficient for ag-
gregation of anchorless F. This conclusion is also sup-
ported by the finding that mutant 131–134, which is
cleaved at site I but not at site II, remains unaggregated.
The unaggregated molecules of anchorless F sedi-
menting near the top of a sucrose density gradient (Fig.
2) contained uncleaved F0 and the partially cleaved in-
termediate F1–109 together with a proportion of fully pro-
cessed F1 chains. Similarly, in the case of mutant R108N/
R109N, uncleaved F0 was found in the gradient fractions
of lower density together with a proportion of F1. In both
cases, however, the majority of uncleaved F0 and the
intermediates cleaved only at site I were in the gradient
fractions of lower density. The reason for these observa-
tions is not known. However, it is possible that the
presence in a trimer of uncleaved monomers or mono-
mers cleaved only at site I prevents the structural change
of monomers in the trimer cleaved at site II and retains
the trimer in the unaggregated cone-shaped conforma-
tion. This possibility is supported by the presence of F1
and F2 together with F0 and F1–109 in the immunoprecipi-
tates obtained with the anti-F104–117 serum (Fig. 7).
The structural changes in anchorless F that lead to the
formation of rosettes of lollipop-shaped spikes are repro-
duced in the wild-type protein and, even more clearly, in
the mutant 131–134 after trypsin digestion (Figs. 5 and
6). These changes occur irrespective of the incubation
temperature and appear to result from cleavage at site II.
In other paramyxoviruses, cleavage of the F0 precursor
also results in exposure of a new hydrophobic region
(Hsu et al., 1991), in accessibility to site-specific antibod-
ies (Dutch et al., 2001) and in aggregation (Chen et al.,
2001).
Thus, activation of the F protein for membrane fusion
requires cleavage at site II. It is possible, however, that
activation may be modulated by the presence of partially
cleaved intermediates in the same oligomer that retains
FIG. 7. Immunoprecipitation of 35S-labeled anchorless F from culture supernatants: HEp-2 cells were infected with the vaccinia recombinant
VAC-FTM or with the parental virus, vRB12 (VAC), as indicated above each lane. Pro-mixL-[
35S] was added from 4 to 28 h after infection and then the
supernatants were collected and immunoprecipitated with the antisera indicated below each lane. Where indicated, 1 ml of each supernatant was
concentrated to one-tenth of the original volume with either Centricon 3 or Centricon 30. Then, the concentrate was diluted to the original volume with
serum-free medium and concentrates and filtrates were immunoprecipitated with the indicated antisera. Proteins were resolved by SDS–PAGE in
12.5-cm-long gels of 12% polyacrylamide and visualized by autoradiography.
324 RUIZ-ARGU¨ELLO ET AL.
F in a preactive state until its function in virus entry since
such intermediates have been found not only in prepa-
rations of purified F but also in purified virus (Gonza´lez-
Reyes et al., 2001). Alternatively, other components of the
infected cell or the virus particle may interact with the F
protein to maintain the preactive state, even after pro-
teolytic cleavage. The slow rate of entry of HRSV into
cells (Techaarpornkul et al., 2001) could be related to this
need for conversion of F from a preactive to an active
state.
MATERIALS AND METHODS
Purification of anchorless F protein
The recombinant vaccinia virus (VAC-FTM) that ex-
presses an anchorless mutant of the HRSV F protein has
been described (Bembridge et al., 1999). Other vaccinia
recombinants that express mutants of anchorless F with
alterations in either cleavage site I (R108N/R109N) or site
II (131–134) have also been described (Gonza´lez-Reyes
et al., 2001).
HEp-2 cells were infected with the different vaccinia
recombinants at low m.o.i. (0.1–1.0 PFU/cell) in serum-
free Dulbecco’s medium and culture supernatants were
collected 48–72 h later. Cell debris was separated by
centrifugation at 15,300 g for 15 min and the superna-
tants were concentrated and buffer exchanged to PBS by
filtration through polyethersulfone membranes (Vivaflow,
Sartorius) of 100,000-Da exclusion pores. The concen-
trates were loaded onto monoclonal antibody 2F-Sepha-
rose columns (different columns were used for each
mutant to avoid cross-contaminations). The columns
were washed with 20 vol PBS and the material retained
was eluted with 10 vol of 0.1 M glycine–HCl, pH 2.5.
Fractions containing the F proteins, as assessed by
absorbance at 280 nm, were neutralized with saturated
Tris, and concentrated and buffer exchanged to PBS with
Vivaspin (Sartorius).
Antisera
The antisera raised in rabbits against the peptides
255–275 (anti-F255–275) or 104–117 (anti-F104–117, numbers
indicate residues of the F polypeptide) have been de-
scribed (Lo´pez et al., 1993; Gonza´lez-Reyes et al., 2001).
The anti-F26–136 serum was raised in rabbits in the follow-
ing manner: the segment of the F gene that encodes
amino acids 26–136 was amplified with specific primers
and cloned in the GST fusion plasmid pGEX-5X-3 (Amer-
sham) (details of cloning and expression of fused pro-
teins in bacteria will be described elsewhere). The GST-
F26–136 chimeric protein was purified from bacteria ex-
tracts using GSH-Sepharose columns following the
manufacturer’s instructions. A rabbit was inoculated
three times (3 weeks apart) with 100 m GST-F26–136
mixed with complete Freund’s adjuvant. The rabbit was
bled 10 days after the last boost and its serum was
tested for reactivity with anchorless F by Western blot
and ELISA.
Sucrose density centrifugation
Purified anchorless F proteins were loaded onto pre-
formed 10–25% sucrose gradients in PBS. The samples
were centrifuged at 39,000 rpm for 15 h at 4°C in a SW40
rotor. Thirteen 1-ml fractions were collected from the top
of the tubes and aliquots of each fraction were analyzed
by Western blot with the antisera indicated in the figure
legends.
Electron microscopy
Protein samples in PBS were absorbed onto carbon
films and stained with 1% sodium silicotungstate (pH 7.0).
A JEOL 1200 electron microscope, operated at 100 kV,
was used to view the samples. Micrographs were taken
under minimum-dose, accurate defocus conditions to
preserve details to 1.5 nm (Wrigley et al., 1983).
Radioactive labeling and immunoprecipitation of
anchorless F
HEp-2 cells growing in 35-mm petri dishes were in-
fected with either VAC-FTM or the parental vRB12 virus at
an m.o.i. of 5 PFU/cell in Dulbecco’s medium containing
2.5% fetal calf serum. Four hours later, the medium was
replaced by methionine and cysteine-free medium con-
taining 100 Ci/ml Pro-mixL-[35S]. Twenty four hours after
infection the medium was collected and, after removal of
cell debris by centrifugation at 10,000 rpm for 10 min,
incubated with the antibodies indicated in the figure
legends. The antigen–antibody complexes were precip-
itated with protein A-agarose. The immunoprecipitates
were washed with PNS buffer (PBS containing 0.5% Non-
idet P-40 and 0.25 mg/ml of bovine serum albumin) and
finally resuspended in sample buffer for SDS–PAGE and
fluorography.
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